DATA GRAPHICS | Data Byte
Concerns over sanctions latest blow to China biotechs
Shares tumble as investors worry over possible sanctions tied to China response to Ukraine
March 16, 2022 1:49 AM UTC
Jitters over the possibility of sanctions for China stemming from the Ukraine crisis have compounded woes for Chinese biotech stocks, which have already been rattled by the prolonged market downturn, a fresh round of citywide COVID shutdowns, and the specter of delisting raised by U.S. accounting rules.
White House spokesperson Jen Psaki warned this week of “significant consequences” if Beijing provides “military or other assistance” to Russia in the Ukraine conflict. ...